Details for 2019163698

Up to date per 01.04.2026

Actions

Title / Product Name

EXENDIN ZUR VERWENDUNG IN DER BEHANDLUNG VON DIABETES UND ZUR REDUZIERUNG DES KÖRPERGEWICHTS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019163698

EP Publication Number

3524261

E-Number

1639916

Language

PCT Number

Publication Date

14.08.2019 A

13.12.2023 B1

Registration Date

13.12.2023

AT Publication Date

15.01.2024

Application Date

18.08.2006

Registration Number

Priorities

03.03.2006

77921606 P

19.08.2005

70960405 P

IPC

A61K 38/26 20060101AFI20190614BHEP

Maximum Duration of Protection

18.08.2026

Owner

Amylin Pharmaceuticals, LLC9360 Towne Centre Drive San Diego, CA 92121US

AstraZeneca Pharmaceuticals LP1800 Concord Pike Wilmington, DEUS

Representative

Dipl.-Ing. Mag. Michael BabelukFlorianigasse 26/31080 WienAT

Inventor

Fineman, Markc/o Amylin Pharmaceuticals, LLC 9360 Towne Centre Drive San Diego, CA California 92121US

Macconell, Leighc/o Amylin Pharmaceuticals, LLC 9360 Towne Centre Drive San Diego, CA California 92121US

Taylor, Kristinc/o Amylin Pharmaceuticals, LLC 9360 Towne Centre Drive San Diego, CA California 92121US

Information about Fees